BIOD in the news
ShareCopied to clipboardAnalyze the latest BIOD news, with a current slightly positive sentiment polarity (0.7) or the entire set.
Latest news
Here are the latest news on this scope:
This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
Leerink upgrades this beaten-down biotech stock, says investors should buy the dip
This little-known biotech stock is a buy that's primed to double in price, Goldman says
This biotech stock is an 'oncology powerhouse' with 40% upside, says Truist Securities
These innovative biotech stocks have a good chance of breaking out in 2025
These 9 biotech stocks have doubled this year and are set to double again, analysts say
'A trove of rebound opportunities': Strategists turn bullish on biotech and more, picking top stocks
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
This biotech stock targeting genetically driven diseases could nearly double, predicts JPMorgan
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news: